Agios Pharmaceuticals, Inc. (AGIO) Discusses Topline Results from RISE UP Phase 3 Trial of Mitapivat in Sickle Cell Disease Transcript
Agios Pharmaceuticals(US:AGIO) Seeking Alpha·2025-11-19 19:33公司活动与议程 - 公司举行Agios Pharmaceuticals投资者电话会议和网络直播，讨论mitapivat治疗镰状细胞病的关键三期RISE UP试验的顶线结果 [1][2] - 会议议程包括公司首席执行官Brian Goff、首席财务官Cecilia Jones、首席商务官Tsveta Milanova等管理层的参与 [4] - 会议幻灯片可在公司官网agios com的投资者栏目获取 [2]